Jpmorgan Chase & CO Biote Corp. Transaction History
Jpmorgan Chase & CO
- $1.22 Trillion
- Q3 2024
A detailed history of Jpmorgan Chase & CO transactions in Biote Corp. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 17,431 shares of BTMD stock, worth $104,411. This represents 0.0% of its overall portfolio holdings.
Number of Shares
17,431
Previous 17,114
1.85%
Holding current value
$104,411
Previous $127,000
23.62%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding BTMD
# of Institutions
83Shares Held
17.7MCall Options Held
0Put Options Held
0-
325 Capital LLC New York, NY4.55MShares$27.2 Million13.05% of portfolio
-
Bandera Partners LLC New York, NY2.44MShares$14.6 Million5.13% of portfolio
-
Black Rock Inc. New York, NY1.61MShares$9.61 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.42MShares$8.49 Million0.0% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT1.39MShares$8.34 Million0.04% of portfolio
About biote Corp.
- Ticker BTMD
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Care Facilities
- Shares Outstandng 7,574,270
- Market Cap $45.4M
- Description
- biote Corp. operates in medical practice-building business within the hormone optimization space. The company offers a platform for Biote-certified practitioners to optimize imbalances in their patient's hormone, vitamin, and mineral levels, as well as prescribe bioidentical hormone therapies and recommend dietary supplements. It also sells Biot...